Murphy C, Kwan MYW, Chan ELY, Wong JSC, Sullivan S. Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023. Vaccine. 2024 Feb 22:S0264-410X(24)00215-9
A test negative study was carried out from 13 June through to 15 November 2023 enrolling 3183 children hospitalized with acute respiratory illness in Hong Kong. Influenza A and B viruses were detected in 528 (16.6%) children, among which 419 (79.4%) were influenza A(H3N2). The overall vaccine effectiveness against hospitalization associated with any influenza virus infection was estimated as 22.4% (95% CI: -11.7%, 46.1%), and against influenza A(H3N2) specifically was 14.3% (95% CI: -29.2%, 43.2%). Despite the moderate to low VE estimated here, which could be a result of waning immunity and antigenic drift, influenza vaccination remains an important approach to reduce the impact of influenza in children.
See Also:
Latest articles in those days:
- [preprint]Mass mortality at penguin mega-colonies due to avian cholera confounds H5N1 HPAIV surveillance in Antarctica 15 hours ago
- [preprint]How the 1918-1920 Influenza Pandemic Spread Across Switzerland - Spatial Patterns and Determinants of Incidence and Mortality 15 hours ago
- Influenza C Virus in Children With Acute Bronchiolitis and Febrile Seizures 19 hours ago
- Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems 19 hours ago
- Avian Influenza Weekly Update # 1026: 12 December 2025 2 days ago
[Go Top] [Close Window]


